AUH.F EGF THERAMED HEALTH CORP.
- Market cap
- EUR 5.81K
- P/E
- -
- P/B
- 1.37x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Mar 2026.
Is AUH.F undervalued?
Graham numberThe Graham number of EGF THERAMED HEALTH CORP. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
EGF THERAMED HEALTH CORP. fundamental analysis
No fundamental analysis for EGF THERAMED HEALTH CORP. yet.
EGF THERAMED HEALTH CORP. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About EGF THERAMED HEALTH CORP.
EGF Theramed Health Corp. engages in the development of psychedelic drugs for the treatment of mental health problems in Canada. It offers psychedelics for the treatment of conditions, such as treatment-resistant depression, anxiety, PTSD, and depression, as well as natural health and wellness products. The company also explores other medical areas, including weight loss, skin care, and heart disease. EGF Theramed Health Corp. is headquartered in Vancouver, Canada.
Full company profileEGF THERAMED HEALTH CORP. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Mar 31, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
EGF THERAMED HEALTH CORP. annual financial statements (CAD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -989K | -567K | -240K | -274K | -234K |
| EBITDA | -1.35M | -606K | -240K | -209K | -239K |
| Net Income | -1.35M | -623K | -269K | -3.21M | -307K |
| EPS | -0.63 | -0.06 | -0.02 | -0.28 | -0.03 |
| Balance Sheet | |||||
| Total Assets | 179K | 194K | 214K | 22.3K | 19.1K |
| Total Liabilities | 2.51M | 2.67M | 2.92M | 5.93M | 6.11M |
| Shareholders' Equity | -1.02M | -1.14M | -1.34M | -4.52M | -4.68M |
| Cash & Short-term Investments | 15.0K | 11.5K | 9.79K | 13.8K | 10.7K |
| Cash Flow | |||||
| Operating Cash Flow | -993K | -576K | -135K | 29.8K | -117K |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow | -993K | -576K | -135K | 29.8K | -117K |
| Ratios | |||||
| ROA | -755.8% | -321.6% | -125.6% | -14,354.2% | -1,608.9% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROA
- Return on assets: net income divided by total assets.
EGF THERAMED HEALTH CORP. dividends
EGF THERAMED HEALTH CORP. has not paid dividends in the last 4 fiscal years.
Last stock split: 1:20 on Jul 11, 2022.
Who owns EGF THERAMED HEALTH CORP.
- Insiders 0.09%
- Institutions 0.00%
- Public & others 99.91%
- Shares outstanding 11.6M
EGF THERAMED HEALTH CORP. company profile
- Company name
- EGF THERAMED HEALTH CORP.
- Ticker
- AUH.F
- ISIN
- CA2684692023
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Technology
- Fiscal year end
- June
- Address
- Pacific Centre, Vancouver, BC, Canada, V7Y 1C3
- Phone
- 778 331 4303
- Website
- egftheramedhealth.com
About EGF THERAMED HEALTH CORP.
EGF Theramed Health Corp. engages in the development of psychedelic drugs for the treatment of mental health problems in Canada. It offers psychedelics for the treatment of conditions, such as treatment-resistant depression, anxiety, PTSD, and depression, as well as natural health and wellness products. The company also explores other medical areas, including weight loss, skin care, and heart disease. EGF Theramed Health Corp. is headquartered in Vancouver, Canada.
EGF THERAMED HEALTH CORP. management
1- Mr. Kevin Da CostaCEO, Interim CFO & Director